Ajanta Pharma Limited
AJANTPHARM
Rangering i aksjer
#3733
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aksjekurs
$35.95
Markedsverdi
$4.49B
Endring (1 dag)
-1.24%
Endring (1 år)
29.30%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)
Kategori
Healthcare
Antall utestående aksjer for Ajanta Pharma Limited (AJANTPHARM)
Antall utestående aksjer per June 2026: 124.94M
Ifølge Ajanta Pharma Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 124.94M. Ved slutten av March 2024 hadde selskapet 125.92M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Ajanta Pharma Limited (AJANTPHARM) fra 2005 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 124.94M | -0.19% |
| 2025 | 125.17M | -0.59% |
| 2024 | 125.92M | -1.72% |
| 2023 | 128.12M | -1.19% |
| 2022 | 129.66M | -0.73% |
| 2021 | 130.62M | -0.21% |
| 2020 | 130.89M | -0.84% |
| 2019 | 132.00M | 0.00% |
| 2018 | 132.00M | 0.00% |
| 2017 | 132.01M | 0.01% |
| 2016 | 131.99M | 0.07% |
| 2015 | 131.91M | 0.07% |
| 2014 | 131.81M | 0.04% |
| 2013 | 131.75M | 0.02% |
| 2012 | 131.72M | 0.00% |
| 2011 | 131.72M | 0.00% |
| 2010 | 131.72M | 0.00% |
| 2009 | 131.72M | 0.00% |
| 2008 | 131.72M | 0.00% |
| 2007 | 131.72M | 0.00% |
| 2006 | 131.72M | 0.00% |
| 2005 | 131.72M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,820.46% |
IN
|
